Merrimack Pharmaceuticals, Inc.$15.14 %
Analyst Rating: Hold
Stock Details
CEO
Gary L. Crocker
Sector
Healthcare
Industry
Biotechnology
Full Time Employees
0
Address
One Broadway, Cambridge, MA, 02142
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
Top Competitors
Income Statement
Financials
Selected Year
Revenue Estimates
EPS Estimates
Net Income Estimates
Price target for Merrimack Pharmaceuticals, Inc. $15.14
$0
Min Forecast(+0% )
$249.61
Avg Forecast( +0% )
$325
Max Forecast(+0%)
EPS
Revenue
Institutional Holder
Loading institutional holder data...
Congress Tracker
Showing 0 of 0 results
Insider Trading of Key Employees
Showing 0 of 0 results